Title |
Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm.
|
---|---|
Published in |
The AMA Journal of Ethic, November 2022
|
DOI | 10.1001/amajethics.2022.1063 |
Pubmed ID | |
Authors |
Kevin Schulman, Barak Richman |
Abstract |
Negative health consequences stemming from the financial burden of care on patients and their loved ones are documented as financial toxicity in the literature, and these consequences should be included in informed consent discussions during patient-clinician interactions. However, codes of medical ethics have yet to require obtaining consent to financial costs, even as the No Surprises Act, effective on January 1, 2022, requires some clinicians to facilitate informed financial consent prior to an out-of-network elective service as a means of avoiding arbitration. This article discusses how this requirement can be more broadly applied to informed consent for any intervention. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 8 | 73% |
South Sudan | 1 | 9% |
Unknown | 2 | 18% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 45% |
Scientists | 3 | 27% |
Practitioners (doctors, other healthcare professionals) | 3 | 27% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 4 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 1 | 25% |
Student > Doctoral Student | 1 | 25% |
Student > Master | 1 | 25% |
Unknown | 1 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 2 | 50% |
Business, Management and Accounting | 1 | 25% |
Unknown | 1 | 25% |